Peter Svennilson, 10% Owner at RAPT Therapeutics, Inc. (RAPT), sold 172,723 shares at $30.94 ($5.4M) on 2021-08-23, disclosed to the SEC on 2021-08-24.
Open-market sale of $5.4M RAPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.07 | 1,670 | $50K | 0.9% |
| 2 | $30.07 | 1,670 | $50K | 0.9% |
| 3 | $30.08 | 1,429 | $43K | 0.8% |
| 4 | $30.09 | 1,440 | $43K | 0.8% |
| 5 | $30.92 | 7,278 | $225K | 4.2% |
| 6 | $30.92 | 7,278 |
| $225K |
| 4.2% |
| 7 | $30.93 | 7,605 | $235K | 4.4% |
| 8 | $30.93 | 7,605 | $235K | 4.4% |
| 9 | $30.94 | 8,204 | $254K | 4.7% |
| 10 | $30.94 | 8,204 | $254K | 4.7% |
| 11 | $31.40 | 13,623 | $428K | 7.9% |
| 12 | $31.40 | 13,623 | $428K | 7.9% |
| 13 | $31.41 | 12,969 | $407K | 7.5% |
| 14 | $31.41 | 12,969 | $407K | 7.5% |
| 15 | $31.42 | 12,354 | $388K | 7.2% |
| 16 | $31.42 | 12,354 | $388K | 7.2% |
| 17 | $32.35 | 2,200 | $71K | 1.3% |
| 18 | $32.38 | 2,100 | $68K | 1.3% |
| 19 | $32.39 | 2,007 | $65K | 1.2% |
| 20 | $32.39 | 2,007 | $65K | 1.2% |
| 21 | $30.79 | 2,200 | $68K | 1.3% |
| 22 | $30.81 | 2,300 | $71K | 1.3% |
| 23 | $30.94 | 4,318 | $134K | 2.5% |
| 24 | $30.94 | 4,318 | $134K | 2.5% |
| 25 | $31.76 | 3,463 | $110K | 2.0% |
| 26 | $31.76 | 3,463 | $110K | 2.0% |
| 27 | $31.76 | 3,486 | $111K | 2.0% |
| 28 | $31.76 | 3,486 | $111K | 2.0% |
| 29 | $31.77 | 7,100 | $226K | 4.2% |
| Total | $31.28 avg | 172,723 | $5.4M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RVMD | SELL | 2021-04-28 | $6.5M | — | Filing → |